Free Trial
NASDAQ:ME

23andMe (ME) Stock Price, News & Analysis

23andMe logo
$0.50 -0.27 (-35.32%)
Closing price 03/28/2025
Extended Trading
$0.50 0.00 (0.00%)
As of 03/28/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About 23andMe Stock (NASDAQ:ME)

Key Stats

Today's Range
$0.60
$1.10
50-Day Range
$0.50
$0.50
52-Week Range
$0.53
$10.81
Volume
29.28 million shs
Average Volume
1.48 million shs
Market Capitalization
$13.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Receive ME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 23andMe and its competitors with MarketBeat's FREE daily newsletter.

ME Stock News Headlines

A 23andMe saliva collection kit is shown on March 25, 2025, in Oakland, Calif
Anne Wojcicki's nonprofit gets court approval to buy 23andMe for $305 million
Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to buy 23andMe — the genetic testing company she cofounded...
A 23andMe saliva collection kit is shown on March 25, 2025, in Oakland, Calif
One Tech Tip: How to protect your 23andMe genetic data
Remember 23andMe...
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

ME Stock Analysis - Frequently Asked Questions

23andMe's stock was trading at $3.25 at the beginning of 2025. Since then, ME shares have decreased by 84.7% and is now trading at $0.4980.

23andMe Holding Co. (NASDAQ:ME) issued its earnings results on Tuesday, January, 28th. The company reported ($1.02) earnings per share for the quarter. 23andMe had a negative net margin of 183.39% and a negative trailing twelve-month return on equity of 170.07%.

23andMe's stock reverse split on Wednesday, October 16th 2024.The 1-20 reverse split was announced on Friday, October 11th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, October 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 23andMe investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
1/28/2025
Today
7/09/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ME
CIK
1804591
Fax
N/A
Employees
770
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$666.70 million
Net Margins
-183.39%
Pretax Margin
-186.76%

Debt

Sales & Book Value

Annual Sales
$208.78 million
Cash Flow
$0.54 per share
Price / Cash Flow
0.93
Book Value
$2.34 per share
Price / Book
0.21

Miscellaneous

Free Float
19,766,000
Market Cap
$13.36 million
Optionable
Not Optionable
Beta
1.19
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:ME) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners